Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados BJID (2) BJMBR (1) Autor Anselmo,L.M.P. (1) Araújo-Filho,João Alves de (1) Bellissimo-Rodrigues,F. (1) Bollela,V.R. (1) Feliciano,C.S. (1) Junqueira-Kipnis,Ana Paula (1) Kipnis,André (1) Lemos,Antônio Carlos Moreira (1) Matos,Eliana Dias (1) Nascimento,M.M.P. (1) Pocente,R.H.C. (1) Severo,Klaus Andrade (1) Silveira,Colombina da (1) Sousa,Eduardo Martins de (1) Sousa,Patrícia Tavares Pereira de (1) Vasconcelos-Jr,Arioldo Carvalho (1) Vieira,Ludmila Ferreira (1) Mais... Palavra-chave Multidrug-resistant tuberculosis (3) Diagnosis (1) MDR-TB (1) Molecular diagnostic techniques (1) Mycobacterium tuberculosis (1) Review (1) Risk factors (1) Treatment (1) Tuberculosis (1) Mais... Tipo do documento Info:eu-repo/semantics/article (2) Info:eu-repo/semantics/report (1) Ano 2015 (1) 2013 (1) 2008 (1) País Brazil (3) Idioma Inglês (3)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 3 Primeira ... 1 ... Última Multidrug-resistant tuberculosis BJID Lemos,Antônio Carlos Moreira; Matos,Eliana Dias. Despite the efforts made worldwide to reduce the number of cases of drug-susceptible tuberculosis, multidrug-resistant tuberculosis (MDR-TB) constitutes an important public health issue. Around 440,000 new cases of MDR-TB are estimated annually, although in 2008 only 7% of these (29,423 cases) were notified. The laboratory tests for diagnosing resistance may be phenotypic (based on culture growth in the presence of drugs) or genotypic (i.e. identification of the presence of mutations that confer resistance). The urgent need for a rapid means of detecting resistance to anti-TB drugs has resulted in the development of many genotypic methods over recent years. The treatment of MDR-TB is expensive, complex, prolonged (18-24 months) and associated with a higher... Tipo: Info:eu-repo/semantics/article Palavras-chave: Multidrug-resistant tuberculosis; Review; Diagnosis; Treatment. Ano: 2013 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702013000200018 Multidrug-resistant tuberculosis: case reports study in a central state of Brazil BJID Araújo-Filho,João Alves de; Vasconcelos-Jr,Arioldo Carvalho; Sousa,Eduardo Martins de; Silveira,Colombina da; Sousa,Patrícia Tavares Pereira de; Severo,Klaus Andrade; Vieira,Ludmila Ferreira; Kipnis,André; Junqueira-Kipnis,Ana Paula. Multidrug-resistant tuberculosis (MDR-TB) is an emerging and worrisome health problem that threatens tuberculosis (TB) control worldwide. The clinical management of MDR-TB is a complex issue associated with the use of multiple drugs for a long period, usually accompanied by side effects and high costs. The objective of this work was to relate cases of MDR-TB occurring in Goiás, a central state of Brazil. We related five cases of MDR-TB, three women and two men. All were pulmonary cases. Three were in their second treatment and two in their first treatment. Surgical pulmonary resection was performed in one case. One death occurred. Lack of adherence, gastric intolerance to anti-TB drugs and poor clinical management were the main aspects related to the... Tipo: Info:eu-repo/semantics/report Palavras-chave: Tuberculosis; Multidrug-resistant tuberculosis; MDR-TB; Mycobacterium tuberculosis. Ano: 2008 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702008000100020 Role of a GenoType MTBDRplus line probe assay in early detection of multidrug-resistant tuberculosis at a Brazilian reference center BJMBR Feliciano,C.S.; Nascimento,M.M.P.; Anselmo,L.M.P.; Pocente,R.H.C.; Bellissimo-Rodrigues,F.; Bollela,V.R.. Resistance to Mycobacterium tuberculosis is a reality worldwide, and its diagnosis continues to be difficult and time consuming. To face this challenge, the World Health Organization has recommended the use of rapid molecular tests. We evaluated the routine use (once a week) of a line probe assay (Genotype MTBDRplus) for early diagnosis of resistance and for assessment of the main related risk factors over 2 years. A total of 170 samples were tested: 15 (8.8%) were resistant, and multidrug resistance was detected in 10 (5.9%). The sensitivity profile took 3 weeks (2 weeks for culture and 1 week for rapid testing). Previous treatment for tuberculosis and the persistence of positive acid-fast smears after 4 months of supervised treatment were the major risk... Tipo: Info:eu-repo/semantics/article Palavras-chave: Multidrug-resistant tuberculosis; Molecular diagnostic techniques; Risk factors. Ano: 2015 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2015000800759 Registros recuperados: 3 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco